MeSH tree: D23.529.374.465.162
A Northwestern Medicine study has uncovered new insights that may aid in understanding and potentially treating one of the most common and aggressive forms of non-Hodgkin lymphoma, according to findings published in Science ...
Sep 1, 2025
0
27
A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, a rare but life-threatening ...
Jul 8, 2025
0
32
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 ...
Apr 29, 2025
0
55
T cell therapies, which use genetically-engineered T cells of the human immune system as therapeutics, are revolutionizing medical oncology by effectively treating previously incurable blood cancers. However, their success ...
Aug 9, 2024
0
39
Metastasis has always been enemy number one in malignant tumors, as it is the primary cause of cancer-related deaths. It is now widely accepted that the so-called pre-metastatic microenvironment, which means a suitable soil ...
Jul 30, 2024
0
27
Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunotherapy treatments, such as CAR T-cell therapy, against solid tumors. T cells are specialized ...
Nov 1, 2023
0
74
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that IL-21, a soluble molecule involved in activating the immune system, can be a potential therapeutic target to help reduce endocrine autoimmune ...
May 17, 2023
0
67
